SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 26, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The CEO's sales are routine cashless exercise-and-sell transactions, not a bearish signal. Monitor for any unexpected insider buying or material corporate events (earnings, pipeline updates) that could shift the narrative. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$527.91
T+0 close · Aug 26, 2026 · via day close
Latest settled
−9.94%
T+20 · $475.45 · next T+60 in 3d
Vs SPY
−9.97%
α at T+20
Latest observation
+14.15%
T+55 · FF3 residual α
  1. T+0 · Aug 27 $527.91entry
  2. T+1 · 3mo ago −2.36%α −2.13% · $515.46
  3. T+5 · 3mo ago −7.14%α −7.40% · $490.24
  4. T+20 · 8w ago −9.94%α −9.97% · $475.45
  5. T+56 · todayOpen
  6. T+60 · in 3d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt executed a large cluster of open-market sales totaling approximately $12.5M over Aug 21-25, alongside derivative exercises. EVP Paul Mahon sold $101K. The CEO's sales represent about 0.06% of UTHR's $22.2B market cap, falling below the 0.1% materiality threshold for insider sales. Per academic literature, insider sales are weak predictors and this cluster is likely liquidity-driven following option exercises, not a bearish signal. The filing is routine and neutral.

Key Financial Metrics

Direction
selling
Total Value
$12.6M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$12.5M in open-market shares over Aug 21-25, 2026, following derivative exercises at $135.42/share and $0.
  • EVP & General Counsel Paul Mahon sold 192 shares for ~$101K on Aug 20, 2026.
  • Total open-market sales of ~$12.6M represent ~0.06% of UTHR's $22.2B market cap, below the 0.1% materiality threshold.
  • All CEO sales were preceded by same-day derivative exercises, consistent with a cashless exercise-and-sell pattern for tax/expense purposes.
  • No other insiders (directors, officers) reported open-market purchases in the cluster window.

Financial Impact

CEO sold ~$12.5M in shares, representing 0.06% of market cap, immaterial relative to company size.

dilution

Risk Factors

  • CEO selling pattern could be misinterpreted by the market as a negative signal despite being routine.
  • No insider buying to offset the selling, continued absence of insider purchases could indicate lack of conviction at current valuation.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1787810509446

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 27, 2026